There is no Press for this Ticker
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Immuron Limited - Warrants Questions & Anwsers

Q

How do I buy Immuron Limited - Warrants (IMRNW) stock?

A

You can purchase shares of Immuron Limited - Warrants (NASDAQ: IMRNW) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuron Limited - Warrants's (IMRNW) competitors?

A

There are no as such competitors for Immuron Limited - Warrants.

Q

What is the target price for Immuron Limited - Warrants (IMRNW) stock?

A

There is no analysis for Immuron Limited - Warrants

Q

Current Stock Price for Immuron Limited - Warrants (IMRNW)?

A

The stock price for Immuron Limited - Warrants (NASDAQ: IMRNW) is $0.46 last updated Fri Jan 21 2022 17:05:54 GMT+0000 (Coordinated Universal Time).

Q

Does Immuron Limited - Warrants (IMRNW) pay a dividend?

A

There are no upcoming dividends for Immuron Limited - Warrants.

Q

When is Immuron Limited - Warrants (NASDAQ:IMRNW) reporting earnings?

A

Immuron Limited - Warrants does not have any upcoming earnings scheduled.

Q

Is Immuron Limited - Warrants (IMRNW) going to split?

A

There is no upcoming split for Immuron Limited - Warrants.

Q

What sector and industry does Immuron Limited - Warrants (IMRNW) operate in?

A

Immuron Limited - Warrants is in the sector and industry. They are listed on the NASDAQ.